The role of complement in experimental autoimmune myasthenia gravis

Por Kusner, Linda L., Kaminski, Henry J.
Publicado em 2012

Effect of complement and its regulation on myasthenia gravis pathogenesis

Por Kusner, Linda L, Kaminski, Henry J, Soltys, Jindrich
Publicado no Expert Rev Clin Immunol (2008)

CELL SURFACE COMPLEMENT REGULATORS MODERATE EXPERIMENTAL MYASTHENIA GRAVIS PATHOLOGY

Por KUSNER, LINDA L., HALPERIN, JOSE A., KAMINSKI, HENRY J.
Publicado no Muscle Nerve (2012)

Serum Metabolomic Response of Myasthenia Gravis Patients to Chronic Prednisone Treatment

Por Sengupta, Manjistha, Cheema, Amrita, Kaminski, Henry J., Kusner, Linda L.
Publicado em 2014

Targeting Therapy to The Neuromuscular Junction: Proof of Concept

Por Kusner, Linda L, Satija, Namita, Cheng, Georgiana, Kaminski, Henry J
Publicado no Muscle Nerve (2014)

Extraocular Muscle Susceptibility to Myasthenia Gravis Unique Immunological Environment?

Por Soltys, Jindrich, Gong, Bendi, Kaminski, Henry J., Zhou, Yuefang, Kusner, Linda L.
Publicado em 2008

Perimysial Fibroblasts of Extraocular Muscle, as Unique as the Muscle Fibers

Por Kusner, Linda L., Young, Andrew, Tjoe, Steven, Leahy, Patrick, Kaminski, Henry J.
Publicado em 2010

The Presence of Survivin on B Cells from Myasthenia Gravis Patients and the Potential of an Antibody to a Modified Survivin Peptide to Alleviate Weakness in an Animal Model

Por Zhang, Xiangyang, Ciesielski, Michael, Fenstermaker, Robert A., Kaminski, Henry J., Kusner, Linda L.
Publicado no J Immunol (2020)

Survivin as a Potential Mediator to Support Autoreactive Cell Survival in Myasthenia Gravis: A Human and Animal Model Study

Por Kusner, Linda L., Ciesielski, Michael J., Marx, Alexander, Kaminski, Henry J., Fenstermaker, Robert A.
Publicado em 2014

Differential RNA Expression Profile of Skeletal Muscle Induced by Experimental Autoimmune Myasthenia Gravis in Rats

Por Kaminski, Henry J., Himuro, Keiichi, Alshaikh, Jumana, Gong, Bendi, Cheng, Georgiana, Kusner, Linda L.
Publicado no Front Physiol (2016)

Guidelines for pre-clinical assessment of the acetylcholine receptor-specific passive transfer myasthenia gravis model - recommendations for methods and experimental designs

Por Kusner, Linda L., Losen, Mario, Vincent, Angela, Lindstrom, Jon, Tzartos, Socrates, Lazaridis, Konstantinos, Martinez-Martinez, Pilar
Publicado no Exp Neurol (2015)

MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis

Por Sengupta, Manjistha, Wang, Bi-Dar, Lee, Norman H., Marx, Alexander, Kusner, Linda L., Kaminski, Henry J.
Publicado no PLoS One (2018)

Biomarker development for myasthenia gravis

Por Kaminski, Henry J., Kusner, Linda L., Wolfe, Gil I., Aban, Inmaculada, Minisman, Greg, Conwit, Robin, Cutter, Gary
Publicado em 2012

Novel Complement Inhibitor Limits Severity of Experimentally Myasthenia Gravis

Por Soltys, Jindrich, Kusner, Linda L., Young, Andrew, Richmonds, Chelliah, Hatala, Denise, Gong, Bendi, Shanmugavel, Vaithesh, Kaminski, Henry J.
Publicado em 2009

Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis

Por Li, Yan, Tu, Zhidan, Qian, Shiguang, Fung, John J., Markowitz, Sanford D., Kusner, Linda L., Kaminski, Henry J., Lu, Lina, Lin, Feng
Publicado no J Immunol (2014)

The Role of Osteopontin and Its Gene on Glucocorticoid Response in Myasthenia Gravis

Por Xie, Yanchen, Li, Hai-Feng, Sun, Liang, Kusner, Linda L., Wang, Shuhui, Meng, Yunxiao, Zhang, Xu, Hong, Yu, Gao, Xiang, Li, Yao, Kaminski, Henry J.
Publicado no Front Neurol (2017)

Investigational RNAi Therapeutic Targeting C5 Is Efficacious in Pre-clinical Models of Myasthenia Gravis

Por Kusner, Linda L., Yucius, Kristina, Sengupta, Manjistha, Sprague, Andrew G., Desai, Dhruv, Nguyen, Tuyen, Charisse, Klaus, Kuchimanchi, Satya, Kallanthottathil, Rajeev, Fitzgerald, Kevin, Kaminski, Henry J., Borodovsky, Anna
Publicado no Mol Ther Methods Clin Dev (2019)

Advances in Autoimmune Myasthenia Gravis

Publicado em 2020